A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients

A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients

ABSTRACT Lyme disease is the most common vector-borne disease in the United States, with an estimated incidence of 300,000 infections annually. Antibiotic intervention cures Lyme disease in the majority of cases; however, 10 to 20% of patients develop posttreatment Lyme disease syndrome (PTLDS), a d...

Full description

Bibliographic Details
Main Authors: Madeleine Morrissette, Norman Pitt, Antonio González, Philip Strandwitz, Mariaelena Caboni, Alison W. Rebman, Rob Knight, Anthony D’Onofrio, John N. Aucott, Mark J. Soloski, Kim Lewis
Format: Article
Language:English
Published: American Society for Microbiology 2020-10-01
Series:mBio
Subjects:
Lyme disease
diagnostics
microbial communities
microflora
tick-borne pathogens
Online Access:https://journals.asm.org/doi/10.1128/mBio.02310-20

Internet

https://journals.asm.org/doi/10.1128/mBio.02310-20

Similar Items